Biotech ETFs in Focus
from ETF Prime
Brad Loncar, Head of Loncar Investments, joins us in studio to spotlight the index behind the Loncar Cancer Immunotherapy ETF (CNCR) and discuss the innovation occurring in cancer treatment. Nate and Conor also explain why ETFs can be an excellent way to access the biotech space in general.
Embed this episode
No transcript yet.
Similar podcasts
Frequently asked questions
How long is this episode of ETF Prime?
This episode is 55 minutes long.
When was this ETF Prime episode published?
This episode was published on March 8, 2016.
Can I download this ETF Prime episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.